Vagus nerve stimulation for depression: efficacy and safety in a European study
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Vagus nerve stimulation (VNS) therapy is associated with a decrease in seizure frequency in partial-onset seizure patients. Initial trials suggest that it may be an effective treatment, with few side-effects, for intractable depression. Method: An open, uncontrolled European multi-centre study (D03) of VNS therapy was conducted, in addition to stable pharmacotherapy, in 74 patients with treatment-resistant depression (TRD). Treatment remained unchanged for the first 3 months; in the subsequent 9 months, medications and VNS dosing parameters were altered as indicated clinically. Results: The baseline 28-item Hamilton Depression Rating Scale (HAMD-28) score averaged 34. After 3 months of VNS, response rates (⩾50% reduction in baseline scores) reached 37% and remission rates (HAMD-28 score <10) 17%. Response rates increased to 53% after 1 year of VNS, and remission rates reached 33%. Response was defined as sustained if no relapse occurred during the first year of VNS after response onset; 44% of patients met these criteria. Median time to response was 9 months. Most frequent side-effects were voice alteration (63% at 3 months of stimulation) and coughing (23%). Conclusions: VNS therapy was effective in reducing severity of depression; efficacy increased over time. Efficacy ratings were in the same range as those previously reported from a USA study using a similar protocol; at 12 months, reduction of symptom severity was significantly higher in the European sample. This might be explained by a small but significant difference in the baseline HAMD-28 score and the lower number of treatments in the current episode in the European study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of VNS over a period of 3 months resulted in a response rate of 37% and a remission rate of 17%. After 1 year of treatment, the response rate reached 53% and the remission rate reached 33%.”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [113]
In the citing paper
“A European multicenter study demonstrated a positive effect of VNS on depressive symptoms, in patients with treatment-resistant depression (113).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [113]
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410 · cited 2×
“This protocol was very similar to the D01 study conducted in the USA, except that (1) study inclusion required a score o20 on the HAMD-24 (Hamilton, 1967) in the D03 study, as opposed to o20 on the 28-item HAMD (HAMD-28) in the D01 study, (2) the maximum age at entry was 80 in the D03 study and 70…”
ResultRush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial
Handforth, A., DeGiorgio, C. M., Schachter, S. C., Uthman, B. M., Naritoku, D. K., Tecoma, E. S., Henry, T. R., Collins, S. D., Vaughn, B. V., Gilmartin, R. C., et al. (1998) · Neurology · doi:10.1212/wnl.51.1.48 · Cited by 1,107
Keller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864 · cited 1×
“Keller et al. (1992) studied the course of depression treatment prospectively over a 5-year period and found that the recovery rate decreased over time.”
BackgroundLong-term treatment with vagus nerve stimulation in patients with refractory epilepsy
Morris, G. L., Mueller, W. M., & The Vagus Nerve Stimulation Study Group E–E (1999) · Neurology · doi:10.1212/wnl.53.8.1731 · Cited by 724 · cited 1×
“…in patients with treatment-resistant epilepsy and has been demonstrated to be effective in reducing seizure frequency (Ben-Menachem et al. 1994; The Vagus Nerve Stimulation Study Group, 1995 ; Handforth et al. 1998 ; Morris & Mueller, 1999 ; Uthman, 2000 ; Ben-Menachem, 2001; Schachter, 2002).”
BackgroundRush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688 · cited 12×
“While in the first 3 months of VNS therapy output current in the D01 study ranged from 0.25 to 3.00 mA (mean 0.96¡0.54 mA) (Sackeim et al. 2001), in the D02 study output current ranged from 0.25 to 3.00 mA (mean 0.67¡0.33 mA) (Rush et al. 2005a).”
BackgroundResultInfluentialBen‐Menachem, E., Mañon‐Espaillat, R., Ristanovic, R., Wilder, B. J., Stefan, H., Mirza, W., Tarver, W. B., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02482.x · Cited by 683
Groves, D. A., & Brown, V. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.01.004 · Cited by 675
(1995) · Neurology · doi:10.1212/wnl.45.2.224 · Cited by 674 · cited 2×
“…in patients with treatment-resistant epilepsy and has been demonstrated to be effective in reducing seizure frequency (Ben-Menachem et al. 1994; The Vagus Nerve Stimulation Study Group, 1995 ; Handforth et al. 1998 ; Morris & Mueller, 1999 ; Uthman, 2000 ; Ben-Menachem, 2001; Schachter, 2002).”
BackgroundSackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Nemeroff, C. B., Mayberg, H. S., Krahl, S. E., McNamara, J., Frazer, A., Henry, T. R., George, M. S., Charney, D. S., & Brannan, S. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301082 · Cited by 496 · cited 2×
“Reviews on the emerging body of functional neuroimaging [positron emission tomography (PET), single photon emission computed tomography (SPECT), and functional magnetic resonance imaging (fMRI)] effects of VNS have found the data difficult to reconcile, mainly because of the small sample sizes, different diagnoses, di…”
BackgroundVagus nerve stimulation: a new tool for brain research and therapy
George, M. S., Sackeim, H. A., Rush, A. J., Marangell, L. B., Nahas, Z., Husain, M. M., Lisanby, S., Burt, T., Goldman, J., & Ballenger, J. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00308-x · Cited by 461 · cited 1×
“Vagus nerve stimulation (VNS) therapy is a type of treatment where a small electrical pulse is administered through an implanted neurostimulator to a bipolar lead attached to the left vagus nerve (George et al. 2000 ; Kosel & Schlaepfer, 2003 ; Schlaepfer & Kosel, 2004).”
BackgroundThe Medical Management of Depression
Mann, J. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050730 · Cited by 421 · cited 3×
“These medications, in conjunction with certain methods of psychotherapy and electroconvulsive therapy (ECT), are effective at alleviating depressive symptomatology in most patients (Andrews & Nemeroff, 1994 ; Mann, 2005).”
BackgroundEffect of vagus nerve stimulation on serotonergic and noradrenergic transmission
Dorr, A. E., & Debonnel, G. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104166 · Cited by 420 · cited 1×
“…an initial reduction in the firing rates of serotonergic neurones ; in an animal study, raphe neurone firing rates increased progressively over 2 weeks, which could be an explanation for the slow and progressive increase of antidepressant response in clinical VNS studies (Dorr & Debonnel, 2006).”
BackgroundVagus nerve stimulation, side effects, and long-term safety
Ben-Menachem, E. (2001) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200109000-00005 · Cited by 400 · cited 1×
“…in patients with treatment-resistant epilepsy and has been demonstrated to be effective in reducing seizure frequency (Ben-Menachem et al. 1994; The Vagus Nerve Stimulation Study Group, 1995 ; Handforth et al. 1998 ; Morris & Mueller, 1999 ; Uthman, 2000 ; Ben-Menachem, 2001; Schachter, 2002).”
BackgroundRush, A. J., Sackeim, H. A., Marangell, L. B., George, M. S., Brannan, S. K., Davis, S. M., Lavori, P., Howland, R., Kling, M. A., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.024 · Cited by 400
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398 · cited 1×
“…the treatment of depression in an elderly patient group, high placebo response rates are seen particularly with milder depression, but more effectiveness is noted with higher drug–placebo differences in trials with more severe forms of depression (Schatzberg & Kraemer, 2000 ; Lyketsos et al. 2003).”
BackgroundGeorge, M. S., Rush, A. J., Marangell, L. B., Sackeim, H. A., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Moreno, F., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.028 · Cited by 372 · cited 4×
“Response rates as measured by the 24-item Hamilton Depression Rating Scale (HAMD-24) were 29.8% (D02) and 12.5% (TAU, n=104) at 1 year.”
ResultInfluentialVagus nerve stimulation is associated with mood improvements in epilepsy patients
Elger, G., Hoppe, C., Falkai, P., Rush, A. J., & Elger, C. E. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00181-9 · Cited by 365 · cited 1×
“Significant and clinically meaningful antidepressant effects of VNS in epilepsy patients have been described, independent of reduction of seizure frequency (Elger et al. 2000 ; Harden et al. 2000 ; Helmstaedter et al. 2001).”
BackgroundNaritoku, D. K., Terry, W. J., & Helfert, R. H. (1995) · Epilepsy Research · doi:10.1016/0920-1211(95)00035-9 · Cited by 290 · cited 1×
“VNS has been shown to induce c-fos immunolabelling in several forebrain structures, including the posterior cortical amygdaloid nucleus, cingulate and retrosplenial cortex, ventromedial and arcuate hypothalamic nuclei (Naritoku et al. 1995).”
BackgroundMedication resistance and clinical response to electroconvulsive therapy
Prudic, J., Sackeim, H. A., & Devanand, D. P. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90098-p · Cited by 264 · cited 4×
“In the active VNS group (n=112), 15.2% of the patients met criteria for response versus 10.0% in the sham group (Rush et al. 2005a), despite excluding patients with more than six adequate antidepressant medication trials (as measured by the ATHF; Prudic et al. 1990).”
BackgroundMethodInfluentialA review of functional neuroimaging studies of vagus nerve stimulation (VNS)
Chae, J.-H., Nahas, Z., Lomarev, M., Denslow, S., Lorberbaum, J. P., Bohning, D. E., & George, M. S. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00074-8 · Cited by 255 · cited 1×
“…magnetic resonance imaging (fMRI)] effects of VNS have found the data difficult to reconcile, mainly because of the small sample sizes, different diagnoses, different types of concomitant antidepressant therapies and different time-point of scans obtained (Chae et al. 2003; Nemeroff et al. 2006).”
BackgroundAcute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy
Henry, T. R., Votaw, J. R., Pennell, P. B., Epstein, C. M., Bakay, R. A. E., Faber, T. L., Grafton, S. T., & Hoffman, J. M. (1999) · Neurology · doi:10.1212/wnl.52.6.1166 · Cited by 252 · cited 1×
“Preliminary evidence for the mode of action of the putative antidepressant effect was obtained from brain imaging studies indicating that VNS affects the metabolism of limbic structures relevant to mood regulation (Henry et al. 1999).”
BackgroundA Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation
Harden, C. L., Pulver, M. C., Ravdin, L. D., Nikolov, B., Halper, J. P., & Labar, D. R. (2000) · Epilepsy & Behavior · doi:10.1006/ebeh.2000.0046 · Cited by 250 · cited 1×
“Significant and clinically meaningful antidepressant effects of VNS in epilepsy patients have been described, independent of reduction of seizure frequency (Elger et al. 2000 ; Harden et al. 2000 ; Helmstaedter et al. 2001).”
BackgroundDunner, D. L., Rush, A. J., Russell, J. M., Burke, M., Woodard, S., Wingard, P., & Allen, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0501 · Cited by 234 · cited 9×
“During the current episode, 38% (28/74) of patients had received ECT.”
BackgroundInfluentialRECOVERY, CHRONICITY, AND LEVELS OF PSYCHOPATHOLOGY IN MAJOR DEPRESSION
Mueller, T. I., & Leon, A. C. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70275-6 · Cited by 234
Vagus nerve stimulation therapy summary: Five years after FDA approval
Schachter, S. C. (2002) · Neurology · doi:10.1212/wnl.59.6_suppl_4.s15 · Cited by 178 · cited 2×
“…in patients with treatment-resistant epilepsy and has been demonstrated to be effective in reducing seizure frequency (Ben-Menachem et al. 1994; The Vagus Nerve Stimulation Study Group, 1995 ; Handforth et al. 1998 ; Morris & Mueller, 1999 ; Uthman, 2000 ; Ben-Menachem, 2001; Schachter, 2002).”
BackgroundMethodMontgomery, S. A., Rasmussen, J. G. C., & Tanghøj, P. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00008 · Cited by 163 · cited 1×
“Patients who switched to placebo had re-emergence of their depressive symptoms at a significantly higher rate than patients maintained on citalopram (Montgomery et al. 1993).”
BackgroundCerebral blood flow changes during vagus nerve stimulation for depression
Conway, C. R., Sheline, Y. I., Chibnall, J. T., George, M. S., Fletcher, J. W., & Mintun, M. A. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.12.007 · Cited by 150 · cited 1×
“Blood flow increases were found in the orbitofrontal cortex, dorsal and ventral anterior cingulate ; superior and inferior frontal gyri ; cerebellum; and putamen; while decreases were found in temporal and parietal cortex (Conway et al. 2006).”
BackgroundCarpenter, L. L., Moreno, F. A., Kling, M. A., Anderson, G. M., Regenold, W. T., Labiner, D. M., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.025 · Cited by 123 · cited 1×
“…of norepinephrine (NE) and serotonin (5-HT) was seen in patients treated for 3 months compared with pretreatment levels while concentrations of homovanilinic acid in the CSF were increased significantly in treated patients compared to those treated with sham only (Carpenter et al. 2004).”
ResultAntidepressant treatments in the 21st century
Nestler, E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00095-x · Cited by 123 · cited 1×
“A need for the development of alternative treatments for TRD that are effective, have fewer sideeffects or have longer-lasting antidepressant effects has been identified (Nestler, 1998 ; Schlaepfer & Kosel, 2004).”
BackgroundContemporary management of depression
Andrews, J., & Nemeroff, C. B. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90360-3 · Cited by 120 · cited 3×
“These medications, in conjunction with certain methods of psychotherapy and electroconvulsive therapy (ECT), are effective at alleviating depressive symptomatology in most patients (Andrews & Nemeroff, 1994 ; Mann, 2005).”
BackgroundZobel, A., Joe, A., Freymann, N., Clusmann, H., Schramm, J., Reinhardt, M., Biersack, H.-J., Maier, W., & Broich, K. (2005) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.02.010 · Cited by 117 · cited 1×
“The only area of increased flow was found in the middle frontal gyrus (Zobel et al. 2005).”
BackgroundSelf-citationThe Effects of Antidepressants on the Hypothalamic-Pituitary-Adrenal Axis
(2006) · Drug News & Perspectives · doi:10.1358/dnp.2006.19.10.1068007 · Cited by 107 · cited 2×
“Antidepressant drugs, which are associated with modulation of monoaminergic neurotransmission and/or regulation of the hypothalamic–pituitary– adrenal axis (Mason & Pariante, 2006), are effective in improving depressive symptoms in major depression (Mann, 2005).”
BackgroundUse of placebo control groups in evaluating efficacy of treatment of unipolar major depression
Schatzberg, A. F., & Kraemer, H. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00846-5 · Cited by 106 · cited 2×
“First, the patients studied all suffered from severe TRD, and such patients are known to be less likely to show placebo response (Schatzberg & Kraemer, 2000).”
BackgroundHead Orientation and Trajectory of Locomotion during Jumping and Walking in Domestic Chicks
R. Green, P. (1998) · Brain, Behavior and Evolution · doi:10.1159/000006529 · Cited by 105
Memory alterations during acute high-intensity vagus nerve stimulation
Helmstaedter, C., Hoppe, C., & Elger, C. E. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00291-1 · Cited by 86 · cited 1×
“Significant and clinically meaningful antidepressant effects of VNS in epilepsy patients have been described, independent of reduction of seizure frequency (Elger et al. 2000 ; Harden et al. 2000 ; Helmstaedter et al. 2001).”
BackgroundApproving the Vagus-Nerve Stimulator for Depression
Shuchman, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078035 · Cited by 60 · cited 1×
“It has been argued that a controlled design would be unethical, because eligible patients would be too depressed to be taken off their medications and given only sham stimulation (Shuchman, 2007).”
BackgroundVagus Nerve Stimulation for Seizures
Uthman, B. M. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00060-6 · Cited by 51
Beyond the Treatment of Epilepsy: New Applications of Vagus Nerve Stimulation in Psychiatry
Kosel, M., & Schlaepfer, T. E. (2003) · CNS Spectrums · doi:10.1017/s1092852900018988 · Cited by 42 · cited 1×
“Vagus nerve stimulation (VNS) therapy is a type of treatment where a small electrical pulse is administered through an implanted neurostimulator to a bipolar lead attached to the left vagus nerve (George et al. 2000 ; Kosel & Schlaepfer, 2003 ; Schlaepfer & Kosel, 2004).”
BackgroundSelf-citationMechanisms and State of the Art of Vagus Nerve Stimulation
Kosel, M., & Schlaepfer, T. E. (2002) · Journal of Ect · doi:10.1097/00124509-200212000-00004 · Cited by 29 · cited 1×
“The precise mechanism by which VNS might influence depressive symptoms is not known, but VNS clearly has effects on brain function (Kosel & Schlaepfer, 2002 ; Groves & Brown, 2005).”
BackgroundSelf-citationSchlaepfer, T. E., & Kosel, M. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200401000-00004 · Cited by 15 · cited 2×
“A need for the development of alternative treatments for TRD that are effective, have fewer sideeffects or have longer-lasting antidepressant effects has been identified (Nestler, 1998 ; Schlaepfer & Kosel, 2004).”
BackgroundSelf-citationRole of the Placebo Response in the Treatment of Depressive Disorders
Dago, P. L., & Quitkin, F. M. (1995) · CNS Drugs · doi:10.2165/00023210-199504050-00002 · Cited by 4 · cited 1×
“In antidepressant trials, placebo response appears to be less stable than the improvement attributable to drugs (Dago & Quitkin, 1995).”
Background
Research works printed but not linked: 2
- 10.1016/j.biopsych.2005.05.025 · DOI · Paper page
- 1995, COSTART: Coding Symbols for Thesaurus of Adverse Reaction Terms
Cited by
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,520
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“vNS in Depression A European multicenter study demonstrated a positive effect of VNS on depressive symptoms, in patients with treatment-resistant depression (113).”
BackgroundBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“…of 1,855 patients from one systematic review (Daban et al. 2008), two randomized controlled trials (Nahas et al. 2007; Nierenberg et al. 2008), one non-randomized controlled trial (Sperling et al. 2009), and three case series (Sackeim et al. 2007; Franzini et al. 2008; Schlaepfer et al. 2008).”
BackgroundMilev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., Modirrousta, M., Patry, S., Vila-Rodriguez, F., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660033 · Cited by 586
“The median time to response with VNS was estimated to be 9 months in 1 study.(84) In another VNS study (N 1⁄4 74), only 35% of patients had achieved a response by 3 months, but 61.”
MethodParikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Metadata
- Authors
- Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., Rau, H., Hoff, H.-J., Padberg, F., Müller-Siecheneder, F., Audenaert, K., Van den Abbeele, D., Matthews, K., Christmas, D., Stanga, Z., & Hasdemir, M.
- Affiliations
- Johns Hopkins University (US)
- University Hospital Bonn (DE)
- Freie Universität Berlin (DE)
- Beaumont Hospital (IE)
- University Hospital of Umeå (SE)
- National Hospital for Neurology and Neurosurgery (GB)
- Evangelisches Krankenhaus Bielefeld (DE)
- Ludwig-Maximilians-Universität München (DE)
- Ghent University Hospital (BE)
- Ninewells Hospital (GB)
- University Hospital of Bern (CH)
- Lindenhofspital (CH)
- Corresponding author
- Schlaepfer, T. E.
- ORCID
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-01-04
- Volume
- 38
- Issue
- 5
- Pages
- 651-661
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2086712277
- Cited by
- 205
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 13 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 7 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 7 · 2015: 15 · 2014: 11 · 2013: 16 · 2012: 18
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Open Access CRIS of the University of Bern
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- vagus nerve stimulation, treatment-resistant depression, antidepressant efficacy, remission rate, adverse effects, voice change, cough, pharmacotherapy, open-label extension, European patients
- MeSH terms
- Adult, Anticonvulsants, Antidepressive Agents, Bipolar Disorder, Combined Modality Therapy, Major Depressive Disorder, Electric Stimulation Therapy, Europe, Female, Follow-Up Studies, Humans, Male, Middle Aged, Personality Inventory, Safety, Vagus Nerve, Treatment Outcome, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.